QLGN Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 23:00):

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system...

Stats
Šios dienos apimtis	9 087.00
Vidutinė apimtis	65 834.00
Rinkos kapitalizacija	1.83M
EPS	$-0.640 ( 2023-11-14 )
Kita pelno data	( $-0.520 ) 2024-05-21
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.120
ATR14	$0.00700 (2.41%)

Insider Trading

Date	Person	Action	Amount	type
2022-07-11	Abdul-ahad Wajdi	Buy	80 000	Stock Option (Right to Buy)
2022-07-11	Lotz Christopher L.	Buy	100 000	Stock Option (Right to Buy)
2022-07-11	Lotz Christopher L.	Buy	100 000	Stock Option (Right to Buy)
2022-07-11	Arshad Tariq	Buy	102 000	Stock Option (Right to Buy)
2022-07-11	Ritter Ira E.	Buy	40 000	Stock Option (Right to Buy)

INSIDER POWER
100.00
Last 89 transactions
Buy: 8 588 032 \| Sell: 1 076 061

Qualigen Therapeutics Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
LYEL	0.959
ARQQ	0.958
WISA	0.956
FATE	0.954
QTEK	0.953
RPID	0.953
STRC	0.951
NKTX	0.951
LYRA	0.945
GROM	0.944

10 Labiausiai neigiamai susiję koreliacijos
LRFC	-0.955
NWFL	-0.954
STAY	-0.944
LUNA	-0.941
TIPT	-0.939
IBEX	-0.938
IVAC	-0.936
PEBK	-0.935
GLLI	-0.931
CCRC	-0.931

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Qualigen Therapeutics Inc Finansinės ataskaitos

Annual	2023
Pajamos:	$0
Bruto pelnas:	$-4 495.00 (0.00 %)
EPS:	$-2.53

FY	2023
Pajamos:	$0
Bruto pelnas:	$-4 495.00 (0.00 %)
EPS:	$-2.53

FY	2022
Pajamos:	$4.98M
Bruto pelnas:	$680 801 (13.66 %)
EPS:	$-5.48

FY	2021
Pajamos:	$5.65M
Bruto pelnas:	$1.32M (23.37 %)
EPS:	$-6.10

Financial Reports:

No articles found.

Qualigen Therapeutics Inc

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.